Correlates of latent and productive HIV type-1 infection in tonsillar CD4(+) T cells. 1997

B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
Department of Microbiology and Immunology, Centre for Research in Virology, N-5020 Bergen, Norway.

Correlates of virus load and characteristics of virus-producing cells in tonsillar tissue were investigated. Our results suggest that when less than 1:100 tonsillar CD4(+) T cells from individuals infected with HIV type-1 (HIV-1) contain replication competent provirus, the level of CD4(+) T cells in tonsils is comparable to that observed in uninfected individuals. Virus load at or above this level was associated with low CD4 cell numbers in tonsillar tissue. Only a few percent of all infected T cells in tonsillar tissue were active virus producers, with minor differences observed between individuals. Plasma viremia was found to correlate with infectious virus load in tonsillar tissue. With less than 1:1,000 of CD4 cells in lymphoid tissues being involved in active virus production, direct cytopathic effect by HIV-1 on infected CD4 cells is unlikely to fully explain the immunodeficiency seen in AIDS.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014066 Palatine Tonsil A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX. There is one on each side of the oropharynx in the fauces between the anterior and posterior pillars of the SOFT PALATE. Tonsil,Tonsil, Palatine,Palatine Tonsils,Tonsils,Tonsils, Palatine
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017735 Virus Latency The ability of a pathogenic virus to lie dormant within a cell (LATENT INFECTION). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors. Viral Latency,Latencies, Viral,Latencies, Virus,Latency, Viral,Latency, Virus,Viral Latencies,Virus Latencies
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
December 1998, AIDS research and human retroviruses,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
October 2018, Virology journal,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
February 2017, AIDS research and human retroviruses,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
September 2013, Journal of virology,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
August 2018, Cell reports,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
May 2023, The Journal of cell biology,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
January 2016, Journal of clinical & experimental immunology,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
January 2021, Frontiers in immunology,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
August 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
B Rosok, and J E Brinchmann, and P Voltersvik, and J Olofsson, and L Bostad, and B Asjö
January 2012, Journal of virology,
Copied contents to your clipboard!